The claimEvidence B · meta-analysis
Berberine = Nature's Ozempic
The evidence
It lowers HbA1c, a long-term blood-sugar measure, by about 0.7-1% — the same range as metformin, and nowhere near the strength of GLP-1 receptor agonist drugs.
Why the claim spreads
'Nature's version of the expensive famous drug' is an irresistible hook — the nickname caught fire on TikTok by riding Ozempic's fame.
The mechanism, in brief
Berberine is a compound in the Chinese herb huanglian (Coptis); in China it is also sold as huangliansu. In recent years it has been marketed as a natural metformin, mainly for lowering blood sugar and blood lipids. In small randomized trials it did lower both. This story goes through, point by point, how it differs…
Sources (3)
- Yin, J., Xing, H., & Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712–717. Pilot study. Study A: 36 newly diagnosed adults randomized to berberine or metformin 0.5 g three times a day for 3 months; in the berberine group HbA1c fell from 9.5% to 7.5% and fasting glucose from 10.6 to 6.9 mmol/L, similar to metformin. Study B: 48 poorly controlled patients given berberine on top of treatment with no control group; HbA1c 8.1% to 7.3%. Transient gastrointestinal adverse effects in 20 (34.5%) patients (abstract, PMID 18442638).
- Turner, N., Li, J. Y., Gosby, A., To, S. W., Cheng, Z., Miyoshi, H., et al. (2008). Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I. Diabetes, 57(5), 1414-1418. This is the paper that shows berberine inhibits mitochondrial complex I. The story used to credit Brunmair 2004, which tested metformin, rosiglitazone and pioglitazone and never mentions berberine.
- Pirillo, A., & Catapano, A. L. (2015). Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studies. Atherosclerosis, 243(2), 449–461.